Does β-Blockade for Treatment of Refractory Ventricular Fibrillation or Pulseless Ventricular Tachycardia Improve Outcomes?

Ann Emerg Med. 2020 Jul;76(1):42-45. doi: 10.1016/j.annemergmed.2020.01.025. Epub 2020 Mar 16.
No abstract available

Publication types

  • Editorial
  • Review

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use*
  • Anti-Arrhythmia Agents / therapeutic use*
  • Cardiopulmonary Resuscitation
  • Observational Studies as Topic
  • Randomized Controlled Trials as Topic
  • Systematic Reviews as Topic
  • Tachycardia, Ventricular / drug therapy*
  • Tachycardia, Ventricular / physiopathology
  • Treatment Outcome
  • Ventricular Fibrillation / drug therapy*
  • Ventricular Fibrillation / physiopathology

Substances

  • Adrenergic beta-Antagonists
  • Anti-Arrhythmia Agents